European Companies Search Engine
Managing Director: Michael Lutz · Authorized signatory (ppa): W. A. · Change of headquarters: HepaRegeniX GmbH · Address · Capital: €146,668 · Shareholder agreement · Proxy policy · Corporate Purpose Hrb 6 Feb 2020 German Trade Register Announcements, Germany
Overview
Text
HRB 772644: HepaRegeniX GmbH,
Unnamed street ??, 72074 Tübingen, Germany
. GmbH. Partnership agreement of December 17, 2015 with amendment; last modified on March 25, 2019. The shareholders' meeting of December 19 and 2019 decided on the recasting of the partnership agreement. The share capital is increased by EUR 41,586.00 by resolution of the Shareholders' Meeting on the same day. The seat is moved from Ulm (Amtsgericht Ulm HRB 733151) to Tübingen. Business address:
Unnamed street ??, 72074 Tübingen, Germany
. Subject: Development of medicines. Share capital now: share capital: EUR 146,668.00. General representation regulation: If only one managing director is appointed, he alone represents. If several managing directors have been appointed, two represent jointly or one managing director with one authorized representative. Managing Director: Dr. Lutz, Michael, Konstanz, *??.??.????, authorized to represent one another. Individual procurator: Dr. Albrecht, Wolfgang, Ulm, *??.??.????. By virtue of the partnership agreement, the management is authorized to increase the share capital of the company once or several times by issuing new shares against cash deposits by December 31, 2023 (Authorized Capital 2019).
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: HepaRegeniX GmbH, Tübingen, Germany.